Skip to main content

Find Clinical Trials

Home
Conditions
Stage IV Lung Cancer AJCC v8

Clinical trial condition

Stage IV Lung Cancer AJCC v8

Explore clinical trials studying Stage IV Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

123 public trials 44 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Lung Cancer AJCC v8 trial results

Recruiting

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

NCT06910761

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +21 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Recruiting

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

NCT05244239

Conditions: Extensive Stage Lung Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +6 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View Trial Details

Recruiting

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

NCT05501665

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT05733000

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

NCT07543172

Conditions: Advanced Lung Non-Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +7 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Not Yet Recruiting

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

NCT06943664

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Not Yet Recruiting

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

NCT07322341

Conditions: Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

NCT07619599

Conditions: Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

NCT06982222

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details